Reduced capacity for the reactivation of glucocorticoids in rheumatoid arthritis synovial cells: Possible role of the sympathetic nervous system?
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Objective: Cortisol, the biologically active glucocorticoid, is a major endogenous antiinflammatory factor in rheumatoid arthritis (RA). The aim of this study was to examine the local conversion of cortisol to biologically inactive cortisone and vice versa (the cortisol–cortisone shuttle) in RA and osteoarthritis (OA) patients. Methods: Thin‐layer chromatography and phosphorimaging were used to examine the cortisol–cortisone shuttle in mixed synovial cells. Double immunohistochemistry was used to assess the key enzymes 11β‐hydroxysteroid dehydrogenase 1 (11β‐HSD1) and 11β‐HSD2 and their possible cellular locations. Results: Double immunohistochemistry demonstrated 11β‐HSD1/2+ macrophages in the sublining area. The ratio of 11β‐HSD2+ cells to 11β‐HSD1+ cells was significantly higher in RA than in OA patients. Cortisol was converted to inactive cortisone in mixed synovial cells from RA and OA patients, which was largely inhibited by carbenoxolone (11β‐HSD1 and 11β‐HSD2 inhibitor). Using metyrapone to inhibit the 11β‐HSD1 reducing reaction (cortisone → cortisol), we demonstrated that the capacity for reactivation of cortisone to cortisol was significantly higher in OA than in RA patients. Although the capacity for the cortisone–cortisol shuttle was higher in synovial cells from less‐inflamed OA tissue compared with inflamed RA tissue, it was obvious that synovial inflammation in RA, but not OA, was related positively to the reactivation of cortisone. This indicates that in RA, a cause other than typical inflammatory factors inhibits the reactivation of cortisone. Since isoproterenol and adenosine inhibited the cortisol–cortisone shuttle, the loss of sympathetic nerve fibers (loss of β‐adrenergic agonist and adenosine) may be the missing link that accounts for the increased cortisol–cortisone shuttle in RA. Conclusion: This study demonstrates a reduced capacity for local reactivation of cortisone in RA synovial cells. Since synthetic glucocorticoids also use this reactivation shuttle, the results also apply to therapeutic glucocorticoids. This defective reactivation of cortisone may be an important unrecognized pathophysiologic factor in RA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tannin, G. M., Agarwal, A. K., Monder, C., New, M. I., & White, P. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55351-5 · Cited by 436
Tomlinson, J. W., Moore, J., Cooper, M. S., Bujalska, I., Shahmanesh, M., Burt, C., Strain, A., Hewison, M., & Stewart, P. M. (2001) · Endocrinology · doi:10.1210/endo.142.5.8168 · Cited by 222
Cooper, M. S., Rabbitt, E. H., Goddard, P. E., Bartlett, W. A., Hewison, M., & Stewart, P. M. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.6.979 · Cited by 200
The mechanism of cAMP-induced Glucocorticoid Receptor Expression
Dong, Y., Aronsson, M., Gustafsson, J. A., & Okret, S. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)80050-3 · Cited by 135
Cyclic AMP-dependent protein kinase promotes glucocorticoid receptor function.
Gruol, D. J., Campbell, N. F., & Bourgeois, S. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89191-3 · Cited by 94
Glucocorticoid regulation of beta-adrenergic receptors in 3T3-L1 preadipocytes.
Nakada, M. T., Stadel, J. M., Poksay, K. S., & Crooke, S. T. (1987) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10446-x · Cited by 78
Oikarinen, J., Hämäläinen, L., & Oikarinen, A. (1984) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(84)90290-3 · Cited by 62
Li, K. X. Z., Obeyesekere, V. R., Krozowski, Z. S., & Ferrari, P. (1997) · Endocrinology · doi:10.1210/endo.138.7.5232 · Cited by 44
Cited by
Coutinho, A. E., & Chapman, K. E. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.04.005 · Cited by 1,815
11β-hydroxysteroid dehydrogenases: Intracellular gate-keepers of tissue glucocorticoid action
Chapman, K., Holmes, M., & Seckl, J. (2013) · Physiological Reviews · doi:10.1152/physrev.00020.2012 · Cited by 887
Glucocorticoid sensitivity in health and disease
Quax, R. A., Manenschijn, L., Koper, J. W., Hazes, J. M., Lamberts, S. W. J., van Rossum, E. F. C., & Feelders, R. A. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.183 · Cited by 310
11β-hydroxysteroid dehydrogenase 1: translational and therapeutic aspects
Gathercole, L. L., Lavery, G. G., Morgan, S. A., Cooper, M. S., Sinclair, A. J., Tomlinson, J. W., & Stewart, P. M. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1050 · Cited by 196
Cooper, M. S., & Stewart, P. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1412 · Cited by 183
Metadata
- Authors
- Schmidt, M., Weidler, C., Naumann, H., Anders, S., Schölmerich, J., & Straub, R. H.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2005-06
- Volume
- 52
- Issue
- 6
- Pages
- 1711-1720
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2036239608
- Cited by
- 70
- References
- 8
- FWCI
- 3.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reduced capacity for the reactivation of glucocorticoids in rheumatoid arthritis synovial cells: Possible role of the sympathetic nervous system? https://app.cochat.ai/papers/10.1002/art.21091
- The paper
- Schmidt, M., Weidler, C., Naumann, H., Anders, S., Schölmerich, J., & Straub, R. H. (2005). Reduced capacity for the reactivation of glucocorticoids in rheumatoid arthritis synovial cells: Possible role of the sympathetic nervous system? Arthritis & Rheumatism. https://doi.org/10.1002/art.21091
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.